Our findings show that HER-2/low IBC tumors, as opposed to HER-2-zero and Her-2/positive tumors, can be identified as a new subset of inflammatory breast cancer using standardized IHC. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.